Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s

LONDON: Scientists have developed a drug with potential to stop the breakdown of nerves and brain cells that may lead to Alzheimer’s, Parkinson’s and motor neuron disease.

Alzheimer’s disease is the most common type of dementia, which includes memory loss, confusion and problems with speech and understanding.

The drug is made up of “supercharged” vitamin A, which is found in vegetables like sprouts and carrots and miniature cabbages, the Daily Mail reported.

The study showed that vitamin A turns into a chemical called retinoic acid when broken down by the body, which is crucial for the development of the nervous system.

Glimmer of hope: New ‘supercharged’ drug can protect nerve cells that lead to Alzheimer’s
Higher levels of retinoic acid in the body could halt nerve damage and boost the number of nerve cells.

“We are moving forward with a new therapeutic which could be used to help people with Alzheimer’s disease,” Peter McCaffery, lead author and Professor from the Aberdeen University in Scotland, was quoted as saying.

“Our work is still at an early stage but we believe this is a positive development and the new drugs seem to protect nerve cells” he added.

With vitamin A making a difference, it is important to find ways of tackling neurological conditions, McCaffery said.

In addition, the drug may also benefit ALS or Lou Gehrig’s disease, which affects the muscles of the arms, legs, mouth and respiratory system.

  • Related Posts

    Unapproved drops for dry eyes pose risks: Govt

    NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unapproved drops for dry eyes pose risks: Govt

    Unapproved drops for dry eyes pose risks: Govt

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Govt highlights multi-layer framework to curb misleading advertisements

    Govt highlights multi-layer framework to curb misleading advertisements

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Study finds rising resistance to a last-resort antibiotic in Africa

    Study finds rising resistance to a last-resort antibiotic in Africa